Cole Pinnow is CCO at Cogent Biosciences, Inc. (COGT). They have made 1 open-market trade across 1 company since 2025, most recently 2025-12-17.
CIK 0002024135
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $333K since 2025, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| COGT | 311,450 | $9.2M |
Shares reported on the most recent Form 4, priced at the 2025-12-19 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| COGT | BUY | 2025-01-14 | 2025-01-15 | $7.60 | $333K | +9.3% | -1.7% | -40.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.